Table 3. Change in the prevalence of discontinuation a of statin therapy in the patient subgroups during the 5-year exposure period.
| Prevalence ratio b (95% Confidence interval) | ||
|---|---|---|
| Characteristic | Men | Women |
| All | 5.53 (4.58–6.69) | 5.50 (4.48–6.76) |
| Retirement age (years) | ||
| 44–63 | 5.20 (4.00–6.78) | 4.91 (3.78–6.38) |
| 64–68 | 5.88 (4.48–7.72) | 6.46 (4.64–8.99) |
| Educational level | ||
| Compulsory school | 4.53 (3.31–6.20) | 10.33 (5.43–19.65) |
| Upper secondary school | 6.50 (4.72–8.95) | 4.36 (3.32–5.73) |
| University education | 5.59 (3.91–7.98) | 5.94 (4.18–8.44) |
| Married | ||
| Yes | 4.71 (3.50–6.32) | 5.37 (3.92–7.35) |
| No | 6.06 (4.74–7.76) | 5.60 (4.28–7.34) |
| Income (SEK/year) | ||
| <250 000 | 5.68 (4.11–7.85) | 4.74 (3.70–6.07) |
| ≥250 000 | 5.46 (4.32–6.90) | 7.07 (4.93–10.15) |
| Type of retirement | ||
| Statutory | 5.66 (4.51–7.10) | 6.77 (5.07–9.07) |
| Disability | 5.23 (3.70–7.40) | 4.26 (3.19–5.69) |
| Type of prevention | ||
| Primary | 5.46 (4.44–6.73) | 5.49 (4.45–6.78) |
| Secondary c | 5.85 (3.70–9.23) | 5.66 (2.43–13.20) |
Repeated measures log-binomial regression analyses adjusted for age at retirement.
a No purchases during a calendar year.
bThe prevalence ratios of discontinuation are derived from contrasting the prevalence in the last year of follow-up to the prevalence in the first year
c Secondary prevention: previous in- or outpatient hospital visits due to coronary heart disease or cerebrovascular diseases in any year before retirement.